Crossref
Current status of tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) targeting cancer therapy
Annals of Cancer Research and Therapy · 2005
DOI: 10.4993/acrt.13.11 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Cancer Research and Therapy, 2005. Verfasst von Eiji Mori und 2 weiteren Autor:innen. Die Arbeit nennt 64 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mori, E., Motoki, K., & Kataoka, S. (2005). Current status of tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) targeting cancer therapy. Annals of Cancer Research and Therapy. https://doi.org/10.4993/acrt.13.11
Vancouver
Mori E, Motoki K, Kataoka S. Current status of tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) targeting cancer therapy. Annals of Cancer Research and Therapy. 2005. doi:10.4993/acrt.13.11
BibTeX
@article{Mori2005,
author = {Mori, Eiji and Motoki, Kazuhiro and Kataoka, Shiro},
title = {Current status of tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) targeting cancer therapy},
journal = {Annals of Cancer Research and Therapy},
year = {2005},
doi = {10.4993/acrt.13.11}
}
EUVIMED